Dr Lal PathLabs dividend: Rs 5 second interim payout, record date November 11, 2026
Dr Lal PathLabs dividend record date is November 11, 2026. The board declared a second interim dividend of Rs 5 per share, paid within 30 days.
Dr Lal PathLabs dividend record date is November 11, 2026. The company’s board, meeting on November 4, 2026, declared a second interim dividend of Rs 5 per equity share (50% on a face value of Rs 10) for the financial year 2026-27, according to its filing with the stock exchanges.
Dr Lal PathLabs dividend: key dates and amount
| Item | Detail |
|---|---|
| Dividend | Second interim, Rs 5 per equity share |
| Face value | Rs 10 per share (50%) |
| Record date | November 11, 2026 |
| Payment | Within 30 days of declaration |
The record date is the cut-off the company uses to decide which shareholders are eligible for the dividend. The filing does not state an ex-dividend date. Under the exchange’s usual settlement cycle the ex-date is normally the same as the record date, but check the exchange notice before trading.
What else the board decided
The board also approved the unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026, which are attached to the filing. It also named Ms Vasuta Agarwal an additional independent director for a three-year term starting November 4, 2026; members must still approve this by postal ballot.
The board also approved further investment of up to Rs 49.5 crore, in one or more tranches, in Dr. Lal PathLabs FZCO, its wholly owned Dubai subsidiary, for business needs including further investment in Sunshine Healthcare in Ghana.
How the record date works
To receive the dividend, an investor must be on the company’s register of shareholders as of the record date. Because shares settle after a delay, buyers need to purchase before the ex-dividend date to be eligible.
What to watch next
Watch for the exchange’s ex-date notice and the payment, due within 30 days of November 4. For other payouts see our results news section.
This article is a summary for information only and is not investment advice. Figures are as reported by the sources above; please verify with the original filing or report before making any decision.
More Results News
See all →- Biocon Q2 results: net profit halves to Rs 41 crore as revenue rises 2%; here's why
- Exide Industries Q2 results: standalone profit rises 75% to Rs 386 crore on 20% revenue growth
- Zydus Lifesciences Q2 results: net profit falls 27% despite 29% revenue growth
- Sun TV Network declares Rs 3.75 per share interim payout; shareholders must hold stock before 5 November
- Navin Fluorine interim payout of Rs 8 per share: key dates, ex-date and when money arrives